BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2010
View Archived Issues
Japanese researchers discover novel ACAT-2 inhibitors
Read More
AFQ-056 reduces levodopa-induced dyskinesia in Parkinson's disease
Read More
Chugai Pharmaceutical claims novel prodrugs for cancer therapy
Read More
Merz describes new mGlu5 receptor modulators
Read More
Bayer Schering discloses new vasopressin receptor modulators
Read More
Scientists identify potent and selective IDE inhibitors with a new mode of action
Read More
IRX acquires funds to advance anticancer agent citoplurikin
Read More
FDA approves SanBio's phase I/IIa trial of SB-623 for stroke recovery
Read More
Trius and FDA agree on phase III trial protocol for torezolid phosphate
Read More
Interim phase II data presented on vorinostat/gemtuzumab ozogamicin in AML
Read More
MIP-3-alpha level in serum functions as prognostic biomarker in colorectal cancer
Read More
Merck & Co. presents promising clinical data on MK-4827, MK-1775 and MK-0752
Read More
ADL-5859 and ADL-5747 do not meet primary endpoint in phase IIa trial in OA pain
Read More
Covidien and Somanetics announce merger agreement
Read More
Neurocrine and Boehringer to develop GPR119 agonists for type 2 diabetes
Read More
GlaxoSmithKline identifies new orexin receptor antagonists
Read More
CanBas and Takeda to terminate collaboration for anticancer agent CBP-501
Read More
FDA schedules review of Alkermes' Vivitrol sNDA for opioid dependence
Read More
FDA issues PDUFA action date for Orexigen's Contrave obesity therapy
Read More
EC grants orphan status to pralatrexate for cutaneous T-cell lymphoma
Read More
Arno Therapeutics doses first patient in phase I/IIa trial of AR-42
Read More
Mymetics' malaria vaccine produces antibody responses in phase Ib trial
Read More
Inotek begins phase II trial of INO-8875 eye drops in glaucoma
Read More
FDA approves Novartis' Tasigna for newly diagnosed Ph+ CML
Read More
Epogin injection syringe 24000 approved for blood transfusion in Japan
Read More
